SCHEMBL30906386

CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	7/20	0.61

▸	GCGR	P47871	1/20	0.61

▸	GIPR	P48546	1/20	0.61

▸	NR3C1	P04150	2/20	0.58

▸	ECE1	P42892	1/20	0.57

▸	MUS81	Q96NY9	1/20	0.57

▸	KISS1R	Q969F8	6/20	0.56

▸	NPBWR1	P48145	1/20	0.56

▸	RXFP1	Q9HBX9	1/20	0.55

▸	VIPR1	P32241	1/20	0.55

▸	PTH1R	Q03431	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906338	0.97	GLP1R (0.61)	GLP1RGCGRGIPRECE1MUS81
SCHEMBL30906515	0.95	GLP1R (0.64)	GLP1RGCGRGIPRECE1MUS81
SCHEMBL30906526	0.94	GLP1R (0.66)	GLP1RGCGRGIPRECE1MUS81
SCHEMBL29638070	0.93	GLP1R (0.65)	GLP1RGCGRGIPRNR3C1ECE1
SCHEMBL31065542	0.93	GLP1R (0.60)	GLP1RGCGRGIPRNR3C1ECE1
SCHEMBL30988703	0.92	GLP1R (0.60)	GLP1RGCGRGIPRNR3C1ECE1
SCHEMBL30486093	0.92	NPBWR1 (0.56)	GLP1RGCGRGIPRKISS1RNPBWR1
SCHEMBL30486097	0.92	NPBWR1 (0.56)	GLP1RGCGRGIPRKISS1RNPBWR1
SCHEMBL30486091	0.92	NPBWR1 (0.56)	GLP1RGCGRGIPRKISS1RNPBWR1
SCHEMBL31665973	0.92	GLP1R (0.65)	GLP1RGCGRGIPRNR3C1ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed